Pfizer

Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst
Fierce Pharma
Fri, 02/16/18 - 09:29 pm
Remicade
biosimilars
Pfizer
Merck
JNJ
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Yahoo/Reuters
Thu, 02/15/18 - 10:09 am
Merck KGaA
Pfizer
lung cancer
Bavencio
clinical trials
Pfizer taps real world evidence for CVD in new partnership
Pharmafile
Thu, 02/15/18 - 12:04 am
Pfizer
atrial fibrillation
RWE
real world evidence
BC Platforms
Top 10 most productive workforces in biopharma
Fierce Pharma
Mon, 02/12/18 - 11:03 am
Pharma
pharma employees
productivity
Gilead Sciences
Celgene
Pfizer
AbbVie
Biogen
Research in pharma less and less profitable, economic return as little as 3%
GoinPharma
Sat, 02/10/18 - 09:28 am
R&D
GSK
Pfizer
AbbVie, Pfizer in another close TV ad spending race to kick off 2018
Fierce Pharma
Wed, 02/7/18 - 10:02 am
AbbVie
Pfizer
drug ads
television ads
Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J
JD Supra
Tue, 02/6/18 - 08:40 pm
biosimilars
Pfizer
JNJ
antitrust
Remicade
Inflectra
Pfizer, Astellas peg Xtandi expansion on PROSPER data
Biopharma Dive
Mon, 02/5/18 - 07:09 pm
Pfizer
Astellas
Xtandi
prostate cancer
Glaxo, Reckitt Submit Only Bids for Pfizer's Consumer Unit
Yahoo/Bloomberg
Sun, 02/4/18 - 11:57 am
GSK
Reckitt Benckiser
M&A
Pfizer
consumer health
Here's What Pfizer's Saying About Its Future
Motley Fool
Sat, 02/3/18 - 09:13 am
Pfizer
Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls
TheStreet.com
Sat, 02/3/18 - 09:07 am
pharma execs
M&A
earnings
drug pricing
Pfizer
Ian Read
Merck
Ken Frazier
Enrique Conterno
Eli Lilly
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Biopharma Dive
Thu, 02/1/18 - 09:45 pm
Pfizer
drug manufacturing
generics
Momenta Pharmaceuticals
Copaxone
Novartis
The Viagra effect: Sales of Lilly's ED drug Cialis slide after little blue pill goes generic
Fierce Pharma
Wed, 01/31/18 - 03:16 pm
Eli Lilly
Pfizer
erectile dysfunction
Viagra
Cialis
generics
Racing to replace opioids, biopharma is betting on pain drugs with a checkered past
Stat
Wed, 01/31/18 - 11:00 am
opioids
painkillers
NGF inhibitors
Regeneron
Pfizer
Eli Lilly
NGF blockers
Pfizer benefits from tax reform, still vague on M&A
Biopharma Dive
Tue, 01/30/18 - 10:44 pm
Pfizer
tax reform
M&A
What will Pfizer do with tax reform? It won't revive a split, CFO says
Fierce Pharma
Tue, 01/30/18 - 06:17 pm
Pfizer
tax reform
Pfizer profit tops estimates, books $11 bln tax gain
Yahoo/Reuters
Tue, 01/30/18 - 10:55 am
Pfizer
earnings
Pfizer sweeps out a lineup of neuroscience drugs — as well as cancer and NASH programs — into the scrap heap
Endpoints
Tue, 01/30/18 - 09:52 am
Pfizer
Neurosciences
NASH
Bavencio
How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
Biopharma Dive
Mon, 01/29/18 - 11:59 pm
Bristol-Myers Squibb
Pfizer
Warfarin
real world evidence
RWE
bloodthinners
Eliquis
Pfizer's Q4 Earnings Preview: Watching Ibrance And Prevnar Sales
Forbes
Fri, 01/26/18 - 05:27 pm
Pfizer
earnings
Ibrance
Prevnar

Pages